流感A病毒的形态动力学 在RNA合成期间的核糖蛋白复合体.
Diego Carlero1, Shingo Fukuda2, Rebeca Bocanegra3,4
1Centro Nacional de Biotecnología Campus de Cantoblanco, 28049, Madrid, Spain.
ACS nano
|July 16, 2024
概括
流感A病毒 (IAV) 聚合酶驱动病毒核糖蛋白 (vRNP) 内的RNA合成. 研究人员可视化了RNA合成期间的vRNP构造变化,揭示了循环过程并估计了合成速率.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 生物物理学的生物物理.
背景情况:
- 病毒核糖蛋白 (vRNP) 对于RNA病毒复制至关重要.
- 流感A病毒 (IAV) 聚合酶在vRNP中合成RNA,这是病毒RNA (vRNA) 和核蛋白 (NP) 的复合体.
研究的目的:
- 在RNA合成过程中研究IAV重组RNP (rRNP) 的结构动态.
- 了解RNA合成和vRNP循环的机制.
主要方法:
- 使用了高速原子力显微镜 (HS-AFM) 和电子显微镜 (EM).
- 在聚合酶活动期间实时跟踪单个rRNP的结构变化.
主要成果:
- IAV rRNP 呈现出环状组织,可方便观察 NP-vRNA 模板动态.
- 在RNA合成过程中观察到rRNP的定义形态循环,与转录模型保持一致.
- 确定了RNA合成速率的初步估计及其对核酸度和RNA结构的依赖.
- 提供了连续RNA合成周期的证据,表明rRNP循环.
结论:
- 这项研究阐明了RNA合成期间IAVvRNP的动态构造周期.
- 结果提供了对病毒RNA复制和vRNP循环的效率和机制的见解.
相关概念视频
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Ribosomal RNA Synthesis
13.2K
Ribosome synthesis is a highly complex and coordinated process involving more than 200 assembly factors. The synthesis and processing of ribosomal components occurs not only in the nucleolus but also in the nucleoplasm and the cytoplasm of eukaryotic cells.
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
13.2K
Nucleic Acid Structure
6.1K
The pentose sugar in DNA is deoxyribose, while in RNA the pentose sugar is ribose. The difference between the sugars is the presence of the hydroxyl group on the ribose's second carbon and a hydrogen on the deoxyribose's second carbon. The phosphate residue attaches to the hydroxyl group of the 5′ carbon of one sugar and the hydroxyl group of the 3′ carbon of the sugar of the next nucleotide, which forms a 5′ to 3′ phosphodiester linkage.
DNA Structure
DNA...
DNA Structure
DNA...
6.1K
RNA Polymerase II Accessory Proteins
9.2K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
9.2K
Eukaryotic RNA Polymerases
24.1K
RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...
All three eukaryotic RNAPs require specific transcription factors, of which the...
24.1K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K


